Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS

Gut

Volumn 60, Issue 3, 2011, Pages 334-340

  Yu, Derek ^a   Cheeseman, Frank ^a   Vanner, Stephen ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN; LACTULOSE;

ARTICLE; BACTERIAL GROWTH; CLINICAL ARTICLE; CONSTIPATION; FEMALE; HUMAN; HYDROGEN BREATH TEST; IRRITABLE COLON; MALE; ORO CAECAL SCINTIGRAPHY; PRIORITY JOURNAL; SCINTIGRAPHY;

BLIND LOOP SYNDROME; BREATH TESTS; CECUM; CONSTIPATION; DIARRHEA; FEMALE; GASTROINTESTINAL TRANSIT; HUMANS; INTESTINE, SMALL; IRRITABLE BOWEL SYNDROME; LACTULOSE; MALE; RADIOPHARMACEUTICALS; TECHNETIUM;

EID: 79851512688     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.205476     Document Type: Article

References (36)

1. Talley NJ. Irritable bowel syndrome. Intern Med J 2006;36:724-8. (Pubitemid 44563434)
2. Vanner SJ, Depew WT, Paterson WG, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol 1999;94:2912-17. (Pubitemid 29482757)
3. Lembo A, Ameen VZ, Drossman DA. Irritable bowel syndrome: toward an understanding of severity. Clin Gastroenterol Hepatol 2005;3:717-25. (Pubitemid 41116722)
4. Lin HC, Pimentel M. Bacterial concepts in irritable bowel syndrome. Rev Gastroenterol Disord 2005;5(Suppl 3):S3-9.
5. Pimentel M, Lezcano S. Irritable bowel syndrome: bacterial overgrowth - what's known and what to do. Curr Treat Options Gastroenterol 2007;10:328-37. (Pubitemid 47193517)
6. Barbara G, Stanghellini V, Brandi G, et al. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 2005;100:2560-8.
7. Vanner S. The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment. Gut 2008;57:1315-21.
8. Vanner S. The lactulose breath test for diagnosing SIBO in IBS patients: another nail in the coffin. Am J Gastroenterol 2008;103:964-5. (Pubitemid 351501119)
9. Hasler WL. Lactulose breath testing, bacterial overgrowth, and IBS: just a lot of hot air? Gastroenterology 2003;125:1898-900.
10. Mendall MA, Kumar D. Antibiotic use, childhood affluence and irritable bowel syndrome (IBS). Eur J Gastroenterol Hepatol 1998;10:59-62. (Pubitemid 28085501)
11. Maxwell PR, Rink E, Kumar D, et al. Antibiotics increase functional abdominal symptoms. Am J Gastroenterol 2002;97:104-8. (Pubitemid 34059772)
12. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000;95:3503-6.
13. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003;98:412-19. (Pubitemid 36232393)
14. Pimentel M, Mayer AG, Park S, et al. Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci 2003;48:86-92. (Pubitemid 36232767)
15. Bratten JR, Spanier J, Jones MP. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol 2008;103:958-63. (Pubitemid 351501116)
16. 14C-D-xylose and healthy controls. Am J Gastroenterol 2005;100:1566-70.
17. 2) measurements. J Lab Clin Med 1975;85:546-55.
18. Riordan SM, McIver CJ, Walker BM, et al. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 1996;91:1795-803.
19. Thompson WG, Irvine EJ, Pare P, et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002;47:225-35. (Pubitemid 34075042)
20. Rhodes JM, Middleton P, Jewell DP. The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. Scand J Gastroenterol 1979;14:333-6. (Pubitemid 9185710)
21. Read NW, Al-Janabi MN, Bates TE, et al. Interpretation of the breath hydrogen profile obtained after ingesting a solid meal containing unabsorbable carbohydrate. Gut 1985;26:834-42. (Pubitemid 15045200)
22. Simren M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut 2006;55:297-303. (Pubitemid 43268261)
23. Lin HC. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 2004;292:852-8. (Pubitemid 39079672)
24. Posserud I, Stotzer PO, Bjornsson ES, et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007;56:802-8. (Pubitemid 46854194)
25. 2). Am J Gastroenterol 2006;101:S479. Ref Type: Abstract.
26. Prokop EK, Caride VJ, Winchenbach K, et al. Scintigraphic determination of the effect of metoclopramide and morphine on small intestinal transit time. Am J Physiol Imaging 1988;3:201-4. (Pubitemid 19047803)
27. Christl SU, Murgatroyd PR, Gibson GR, et al. Production, metabolism, and excretion of hydrogen in the large intestine. Gastroenterology 1992;102(4 Pt 1):1269-77.
28. 2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther 2009;29(Suppl 1):1-49.
29. Pochart P, Lemann F, Flourie B, et al. Pyxigraphic sampling to enumerate methanogens and anaerobes in the right colon of healthy humans. Gastroenterology 1993;105:1281-5. (Pubitemid 23315299)
30. Macfarlane GT, Gibson GR, Cummings JH. Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 1992;72:57-64.
31. Cann PA, Read NW, Brown C, et al. Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut 1983;24:405-11. (Pubitemid 13089484)
32. Sadik R, Bjornsson E, Simren M. The relationship between symptoms, body mass index, gastrointestinal transit and stool frequency in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2010;22:102-8.
33. Pimentel M, Lin HC, Enayati P, et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol 2006;290:G1089-95.
34. Dear KL, Elia M, Hunter JO. Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome? Dig Dis Sci 2005;50:758-66.
35. Pimentel M, Park S, Mirocha J, et al. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med 2006;145:557-63. (Pubitemid 46780934)
36. Sharara AI, Aoun E, bdul-Baki H, et al. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol 2006;101:326-33. (Pubitemid 43381675)